TNF-α-induced apoptosis in neonatal lymphocytes: TNFRp55 expression and downstream pathways of apoptosis

Genes and Immunity

Volumn 1, Issue 4, 2000, Pages 271-279

  Aggarwal, S ^a   Gollapudi, S ^a   Yel, L ^a   Gupta, A S ^a   Gupta, S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Caspases; Cord blood; FADD; TRADD; TRAF 2

Indexed keywords

CARRIER PROTEIN; CASP3 PROTEIN, HUMAN; CASP8 PROTEIN, HUMAN; CASP9 PROTEIN, HUMAN; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CD3 ANTIGEN; FADD PROTEIN, HUMAN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; LEUKOCYTE ANTIGEN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ADULT; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECT; FEMALE; FETUS BLOOD; HUMAN; METABOLISM; NEWBORN; PHYSIOLOGY; PROTEIN SYNTHESIS; T LYMPHOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; ANTIGENS, CD; ANTIGENS, CD3; APOPTOSIS; CARRIER PROTEINS; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; PROTEIN BIOSYNTHESIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; T-LYMPHOCYTES; TNF RECEPTOR-ASSOCIATED FACTOR 1; TNF RECEPTOR-ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034573757     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363674     Document Type: Article

References (48)

1. Cohen JJ, Duke RC, Fadok VA, Sellins KS. Apoptosis and programmed cell death in immunity. Ann Rev Immunol 1992; 10: 267-293.
2. Osborne BA. Induction of genes during apoptosis: Examples from immune system. Semin Cancer Biol 1995; 6: 27-33.
3. Wallach D. Cell death induced by TNF: a matter of self-control. Trends Biol Sci 1997; 22: 107-109.
4. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281: 1305-1308.
5. Nagata S, Goldstein P. The Fas death factor. Science 1995; 267: 1449-1456.
6. Aggarwal BB, Kohr WK, Hass PE et al. Human tumor necrosis factor production, purification and characterization. J Biol Chem 1985; 260: 2345-2354.
7. Fiers W. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett 1991; 285: 199-212.
8. Beutler B, Cerami A. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem 1988; 57: 505-518.
9. Larrick JW, Wright SC. Cytotoxic mechanisms of tumor necrosis factor-alpha. FASEB J 1990; 4: 3215-3223.
10. Ware CF, VanArsdale S, VanArsdale TL. Apoptosis mediated by the TNF-related cytokine and receptor families. J Cell Biochem 1996; 60: 47-55.
11. Wiegmann K, Schutze S, Kampen E, Himmler A, Machllidt T, Kronke M. Human 55 kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J Biol Chem 1992; 267: 17997-18001.
12. Targalia LA, Ayers TM, Wong GHW, Goeddel DV. A novel domain within the 55 kd TNF receptor signals death. Cell 1993; 74: 845-853.
13. Hsu H, Shu H-B, Pan M-G, Goeddel DV. TRADD-TRAF-2 and TRADD-FADD interactions define two distinct TNF receptor signal transduction pathways. Cell 1996; 84: 299-308.
14. Hsu H, Xiong J, Goeddel DV. The TNF receptor-1 associated protein TRADD signal cell death and NF-kB activation. Cell 1995; 81: 495-504.
15. Vandevoorde V, Haegeman G, Fiers W. Increased expression of trimerized intracellular domains of the human tumor necrosis factor (TNF) p55 receptor elicits TNF effects. J Cell Biol 1997; 137: 1627-1638.
16. Gerli R, Bertotto A, Crupi S et al. Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule. J Immunol 1989; 142: 2583-2589.
17. Wilson CB, Lewis DB, English BK. T cell development in the fetus and neonate. Adv Exper Med Biol 1991; 310: 17-29.
18. Harris DT, Schumacher MJ, Locascio J et al. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci (USA) 1992; 89: 10006-10010.
19. Adkins B. T cell functions in newborn mice and human. Immunol Today 1999; 20: 330-335.
20. Lee SM, Suen Y, Chang L et al. Decreased interleukin 12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-γ, natural killer, and lymphokine-actitivated killer activity by IL-12 in cord blood mononuclear cells. Blood 1996; 88: 945-954.
21. Chalmers IM, Janossy G, Contreras M, Navarrete C. Intracellular cytokine profile of cord and adult blood lymphocytes. Blood 1998; 92: 11-18.
22. Lewis DB, Yu CC, Meyer J et al. Cellular and molecular mechanisms for reduced interleukin 4 and Interferon-γ production by neonatal T cells. J Clin Invest 1990; 87: 194-202.
23. Ehlers S, Smith KA. Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J Exp Mol 1991; 173: 25-36.
24. Granberg C, Hirvonen T, Toivanen P. Cell-mediated lympholysis by human maternal and neonatal lymphocytes: mother's reactivity against neonatal cells and vice versa. I Immunol 1979; 123: 2563-2567.
25. Gathings WE, Kubagawa H, Cooper MD. A distinctive pattern of B cell immaturity in perinatal humans. Immunol Rev 1981; 57: 107-126.
26. Splawski JB, Jelinek DF, Lipsky PE. Delineation of the functional capacity of human neonatal lymphocytes. J Clin Invest 1990; 87: 545-553.
27. Yarchoan R, Nelson DL. A study of the functional capabilities of human neonatal lymphocytes for in vitro specific antibody protection. J Immunol 1983; 131: 1222-1228.
28. Takahashi N, Imanishi K, Nishida H, Uchiyama T. Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen. J Immunol 1995; 155: 5213-5219.
29. McDougal RM, Suitters AJ, Smith H, Yacob MH, Rose ML. Increased cyclosporin sensitivity of T cells from cord blood compared with those from the adult. Clin Exp Immunol 1994; 95: 519-524.
30. Kavelaars A, Zijlstra J, Bakkar JM et al. Increased dexamethasone sensitivity of neonatal leukocytes: different mechanisms of glucocorticoid inhibition of T cell proliferation in adult and neonatal cells. Eur J Immunol 1995; 25: 1346-1351.
31. Clement LT, Vink PE, Bradley G. Novel immunoregulatory functions of phenotypically distinct subpopulations of CD4+ cells in human neonates. J Immunol 1990; 145: 102-108.
32. Pirenne H, Aujard Y, Eljaafari A et al. Comparison of T cell functional changes during childhood with the ontogency of CDw29 and CD45RA expression on CD4+ T cells. Ped Res 1992; 32: 81-86.
33. Akbar AN, Borthwick N, Salmon M et al. The significance of low bcl-2 expressed by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 1993; 178: 427-438.
34. Aggarwal S, Gupta S. Increased apoptosis if T cell subsets in aged humans: altered expression of Fas (CD95), Fas ligand, Bcl-2 and Bax. J Immunol 1998; 160: 1627-1637.
35. Aggarwal S, Gollapudi S, Gupta S. Increased TNF-a-induced apoptosis in lymphocytes from aged humans: changes in TNF-a receptor expression and activation of caspases. J Immunol 1999; 162: 2154-2161.
36. Aggarwal S, Gupta S. Increased activation of caspase 8 and caspase 3 in aging humans. Clin Exp Immunol 1999; 117: 285-290.
37. Gupta S. Molecular and biochemical pathways of apoptosis in lymphocytes from aged humans. Vaccine 2000; 18: 1596-1601.
38. Aggarwal S, Gupta A, Nagata S, Gupta S. Programmed cell death (apoptosis) in cord blood lymphocytes. J Clin Immunol 1997; 17: 63-73.
39. English BK, Burchett SK, English JD et al. Production of lymphotoxin and tumor necrosis factor by human neonatal mononuclear cells. Ped Res 1988; 24: 717-722.
40. Weatherstone K, Rich E. Tumor necrosis factor/cachectin and interleukin-1 secretion by cord blood monocytes from premature and term neonates. Ped Res 1989; 25: 342-346.
41. Harris DT, Schumacher MJ, Loscasio J et al. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci (USA) 1992; 89: 10006-10010.
42. Beg AA, Baltimore D. An essential role for NF-KB in preventing TNF-α-induced cell death. Science 1996; 274: 782-784.
43. Wang C-Y, Mayo MW, Baldwin AS. TNF-a and cancer therapy-induced apoptosis: potential by inhibition of NF-KB. Science 1996; 274: 784-787.
44. Antwerp DJV, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-α-induced apoptosis by NF-κB. Science 1996; 274: 787-789.
45. Park A, Baichwal VR. Systematic mutational analysis of the death domain of the tumor necrosis factor receptor-1-associated protein TRADD. J Biol Chem 1996; 271: 9858-9862.
46. Yeh W-C, Shahinian A, Speiser D et al. Early lethality, functional NF-KB activation and increased sensitivity to TNF-induced cell death in TRAF-2 deficient mice. Immunity 1997; 7: 715-725.
47. Kumar A, Commane M, Flickinger TW, Horvath CM, Stark GR. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 1997; 278: 1630-1632.
48. Wilson CB. Immunological basis of increased susceptibility of the neonate to infection. J Ped 1986; 108: 1-12.